Raju Prasad, CFO: Crispr Therapeutics CRSP Sell · Filed 01/26

Trade details

Type: Insider sale
Amount: $2,104,964.68
Shares · price: 34,972 sh · $60.19 a share
Held after: 6,767 sh
Stock: Crispr Therapeutics CRSP
Person: Raju PrasadCFO
Trade date: 26/01/22
Filed: 26/01/26
Days to filing: 4 days

Sold 83.8% of holdings

Share of holding sold: 83.8%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/23~02/21

Raju Prasad's recent trades

Raju PrasadCFO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$173.5K
3,708 sh
$173.5K
Filed 03/24
Traded 03/23
Raju PrasadCFO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$282.2K
5,848 sh
$282.2K
Filed 03/17
Traded 03/16
Raju PrasadCFO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$194.1K
4,021 sh
$194.1K
Filed 03/17
Traded 03/16
Raju PrasadCFO
Planned sale10b5-1 planCrispr Therapeutics
Planned sale10b5-1 plan
Crispr Therapeutics
CRSP
$2.1M
34,972 sh
$2.1M
Filed 01/22
Traded 01/22
Raju PrasadCFO
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 plan
Crispr Therapeutics
CRSP
$1.1M
18,933 sh
$1.1M
Filed 01/08
Traded 01/06